Abstract. Although the significance of the enterohepatic circulation of bile salts in the solubilization and biliary excretion of cholesterol is well established, little is known about the intrahepatic determinants of biliary cholesterol output. Studies were undertaken to elucidate some of these determinants in the rat. Feeding 1% diosgenin for 1 wk increased biliary cholesterol output and saturation by 400%. Bile flow, biliary bile salt, phospholipid and protein outputs remained in the normal range. When ethynyl estradiol (EE) was injected into these animals, biliary cholesterol output decreased to almost normal levels under circumstances of minor changes in the rates of biliary bile salt and phospholipid outputs. Similarly, when chylomicron cholesterol was intravenously injected into diosgenin-fed animals, biliary cholesterol output significantly decreased as a function of the dose of chylomicron cholesterol administered.
Introduction
Biliary cholesterol represents one of the two major excretory pathways of sterol elimination from the organism. In the last few years, considerable attention has been paid to the regulatory mechanisms of biliary cholesterol output, because a significant number of patients with gallstone disease present abnormally high rates of biliary cholesterol secretion as the primary pathogenic event (1) (2) (3) .
Biliary cholesterol originates from a preformed pool of hepatic free cholesterol (4) (5) (6) (7) (8) . Approximately 15-20% of this precursor pool derives from newly synthesized hepatic cholesterol in man and rat (6, 9) . However, experimental conditions associated with high rates of hepatic cholesterogenesis do not induce absolute changes in biliary cholesterol secretion (7) .
Similarly, the hepatic overload with dietary cholesterol does not drive the excretion of free cholesterol through the canalicular membrane (7, 10) . It is unknown whether some specific serum lipoprotein can deliver preferentially cholesterol into the bile.
Regulation of the rate of biliary cholesterol output is complex and is known to be primarily influenced by the rate of biliary bile salt output in man, rhesus monkey, dog, sheep, and rat (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . The composition of the bile acid pool is also important in determining biliary cholesterol output. For example, the chronic administration of chenodeoxycholic acid or ursodeoxycholic acid to patients with cholesterol gallstones induces a significant reduction in the rate of biliary cholesterol output (12, 17) . This effect, however, is not apparent in the Recent data from this laboratory have suggested the presence of an important intrahepatic determinant of the rate of biliary cholesterol secretion. This regulatory mechanism, dependent on the size of the hepatic free cholesterol pool destined for biliary secretion, is closely connected with the activity of the microsomal acyl-CoA:cholesterol acyltransferase (ACAT)' (EO 2.3.1.26) (19, 20) .
The present investigation was undertaken to define further the interrelationships between the hepatic precursor free cholesterol pool and the rate of biliary cholesterol output. Taking advantage of the observation that diosgenin (5,20a,22a,25 D-Spirosten-3ft-ol) increases hepatic cholesterogenesis, fecal neutral sterol output, and biliary cholesterol concentration in the rat (21) , we studied: the kinetic characteristics of biliary cholesterol output in diosgenin-fed rats; the effect of ethynyl estradiol (EE) and chylomicron cholesterol on the high biliary cholesterol output induced by diosgenin; the interrelationships between biliary cholesterol output, and hepatic cholesterol synthesis and esterification as two possible determinants of the size of the biliary cholesterol precursor pool. These studies demonstrate that biliary cholesterol can be easily dissociated from the rate of biliary bile salt output and that hepatic cholesterol esterification may be the major intrahepatic determinant of the size of the biliary cholesterol precursor pool. Male Wistar rats in the weight range 100-140 g were subjected to reversed light cycling for 2-3 wk before use. The mid-dark point was set at 10 a.m. The animals were fed ground chow that contained cholesterol 13-20 mg%. Some groups received ground chow that contained 0.25-1% (wt/vol) diosgenin for 6 d before the experiments. In another experiment, groups of rats received 1% (wt/vol) diosgenin for different periods of time, from two to six days. Diosgenin was dissolved in chloroform, mixed with the diet, and the solvent evaporated by heating 24 h at 37°C under a hood.
Biliary secretion studies. Initial and bile salt-depleted bile specimens were obtained as previously described ( 19 (19, 20) .
The reaction was performed within the first 24 h after killing the animals between 10:00 and 14:00 h. The microsomes were preincubated for 5 min at 370C and the reaction was initiated by the addition of oleoyl-CoA, specific activity 5,100 dpm/nmol, and a final concentration of 100 Mm in the assay. Initial rates of ACAT activity were measured by incubation for periods of 7 min. All experiments were performed in duplicate.
Determination of hepatic cholesterol synthesis and esterification in isolated hepatocyte. Isolated hepatocytes from normal and diosgeninfed rats were prepared as described by Berry and Friend (23) . These experiments were started between 08:30 and 10:00 in the morning and the incubations were performed usually between 11:00 and 13:00 h. The cells were resuspended in Krebs-Henseleit bicarbonate buffer pH 7.4, which contained 2.5 mM CaCl2. Between 87 and 90% of the cells excluded Trypan Blue. Control rats were always studied in parallel with the diosgenin-fed animals.
The incubations were started by addition of 0.2 ml of cell suspension (7-10 mg of protein) to 0.8 ml of buffer that contained either 0.5 mM bovine serum albumin (fatty acid free), 1 mM [1-'4C]oleic acid (0.75 iCi/ml), or 1.8 mM 2-'4C-acetate (1.6 ACi/ml). The rates of incorporation of oleic acid into cholesteryl oleate was linear as a function of time over the first 15 min, whereas linearity was observed over the first 90 min of incubation in the studies of acetate incorporation into cholesterol. Therefore, the incubation times for the experimental series were fixed in 10 and 60 min for the first and second reaction, respectively. Incubations were performed in 25-ml Erlenmeyer flasks oxygenated with 5% CO2 in 95% 02 at 370C.
The reactions were stopped with 20 vol of chloroform-methanol 2:1 (24) . After separating the two phases with 20% water, the lower phase was removed and evaporated at 450C under nitrogen. In the studies of oleate incorporation into cholesterol ester, the residue was dissolved in chloroform and applied to thin layer chromatoplates. Lipids were separated using a solvent mixture of hexane:ethyl-acetate 9:1 (25 Biliary secretion of newly synthesized cholesterol. To measure the contribution of newly synthesized hepatic cholesterol to biliary cholesterol we used the method of Turley and Dietschy (9) . Briefly, the rats (140-160 g, body weight) were anesthetized with diethyl ether and a PE-10 polyethylene catheter was placed in a tail vein. A bolus of 70 mCi of [H3] water contained in 0.5 ml of 0.9% NaCl was infused at 08:30 under a hood, under negative pressure, and protected with a hygroscopic chamber in the outlet. The animals were left in this hood for 6 h to allow equilibration of the tritiated water in the body compartments of the animals. At the end of this period, a bile fistula was performed under pentobarbital anesthesia. Bile was collected for I h. At the end of this period, blood was collected by aortic puncture and plasma was obtained after centrifugation in sealed tubes for determination of water specific activity. Bile aliquots were saponified under 0.625 N alcoholic KOH at 80'C for 60 min. Sterols were extracted using petroleum ether and precipitated with digitonin (26). After washing and drying under vacuum, the precipitate was dissolved in pyridine. The free sterols were quantitatively extracted with diethyl ether (27) . After evaporation, the extract was used for determinations of mass and radioactivity. The (9) .
Chylomicron preparation and administration. In one series of experiments, chylomicrons were administered to a group of rats. These chylomicrons were obtained from donor animals fitted with a PE-90 polyethylene catheter in the base of the mesentery as described by Bollman, Cain, and Grindlay (28) . Simultaneously, a liquid diet containing one egg yolk per 40 ml of a 8% aminoacid solution, 0.9% NaCl, and 0.2% KC1 was infused through a gastric cannula at a rate of I ml/h by means of a Braun infusion pump (Braun Melsungen A.G., Federal Republic of Germany). Lymph was collected continuously for 2-4 d. The lymph from each animal was collected into sterilized Erlenmeyer flasks containing 150 mg sodium citrate and 1 mg of gentamicin. These flasks were changed every 24 h and were maintained in a cold room at 4°C. The lymph collected from several rats was pooled and centrifuged at 18,000 rpm X 18 h in a SW 27 swingingbucket rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, CA) at 100C. Chylomicrons were resuspended in 0.9% NaCl and dialyzed several times in a total volume of 5 Analytical methods. Bile salts were quantitated by the 3 a-hydroxysteroid dehydrogenase method of Talalay (29). Phospholipids were measured in the chloroform phase of chloroform-methanol extracts by the colorimetric method of Baginski, Fos, and Zak (30) . Free and esterified cholesterol were extracted and separated as previously described (20) . Cholesterol was quantitated by the colorimetric method of Zak (31) . Biliary cholesterol saturation was calculated according to the method of Carey (32) . Biliary and microsomal protein was measured by the method of Lowry, Rosebrough, Farr, and Randall (33) . Biliary proteins were first precipitated with acetic acid and the precipitate was washed with diethyl ether before colour development.
Statistics. Results are presented as the mean±l SD. The values of a and b of the mathematical formulas obtained from the kinetic studies of biliary lipid secretion, and the linear regressions of Fig. 8 , represent the mean± I SE. Differences in mean values were tested for significance using the unpaired t test (34) .
Results
The effect of diosgenin feeding on body weight, bile secretion, and biliary cholesterol saturation. The first series of experiments was undertaken to characterize bile secretion in the diosgeninfed rat. Table I shows that feeding 1% diosgenin for 1 wk is well tolerated by the rat, since body and liver weights remained in the normal range. Similarly, bile flow, biliary bile salt, phospholipid, and protein outputs were normal. However, biliary cholesterol output increased >400% over the control 20 'C in the darkness and were examined daily for a period of 5 d. No precipitates were found and bile samples remained isotropic. The absence of a solid phase in bile specimens from diosgenin-fed rats was expected, since supersaturated cholesterol solutions can remain isotropic for long periods of time (35) . The physicochemical equilibrium of these biles was disturbed by freezing and thawing. After thawing, the bile samples from diosgenin-fed animals appeared turbid, and under polarized light microscopy the field was full with birefringent crystals in the form of parallelepipeds, as is commonly found in supersaturated bile from patients with cholesterol gallstones. In addition, we also found birefringent Kinetic characteristics of biliary lipid outputs in the diosgenin-fed rat. The relationship between cholesterol and phospholipid outputs as a function of bile salt output is shown in Fig. 3 . The secretion of both lipids related to bile salt output by an ascending curve that appeared to pass through the origin in control and diosgenin-fed rats. Although the kinetic characteristics of biliary phospholipid as a function of bile salt output were similar in both groups of rats (panel B, Fig. 3) , it was apparent that the amount of biliary cholesterol secreted per unit of bile salt was considerably higher in the diosgeninfed animal (panel A , Fig. 3 ). The calculated maximal cholesterol output of the diosgenin group was >400% higher than the maximal output of control rats. The relationship between cholesterol output as a function of phospholipid output was linear, as shown in Fig. 4 . This experiment demonstrated that per mole of phospholipid secreted into the bile, almost 450% more biliary cholesterol was secreted in the diosgenin-fed rats.
To study the functional integrity of the biliary apparatus in the diosgenin-fed animals we stimulated bile secretion by overloading the liver cells with exogenous taurocholate (Fig.  5) . After the intravenous infusion of taurocholate at a rate of Table I , three rats infused intravenously with 45 mM taurocholate in 0.9% NaCl at a rate of 0.075 ml/min for a period of 20 min (equivalent to the period of bile collection), and a third group of three rats subjected to acute depletion of the bile acid pool as previously described (19 Taken together, these data permitted the conclusion that the biliary apparatus of the diosgenin-fed animal maintains its functional integrity, in spite of the massive excretion of cholesterol through the canalicular membrane. A toxic effect of diosgenin on the excretory function of the hepatocyte appeared very unlikely as a possible mechanism of the diosgenininduced biliary cholesterol output.
The effect of EE and chylomicron cholesterol on biliary lipid outputs in diosgenin-fed rats. Two series of rats were fed diosgenin for 1 wk and were injected with different daily doses of EE 2 d before the experiments. As shown in Table II , the hormone induced a cholestatic effect reflected in the significantly lower bile flows. Biliary bile salt and phospholipid outputs remained in the normal range in the injected rats with the lower dose of EE. However, these rats (group C) presented an impressive decrement of biliary cholesterol output compared with the rats injected with corn oil (group B). The kinetic characteristics of biliary cholesterol and phospholipid outputs as a function of bile salt output in the EE-injected animal maintained the hyperbolic relationship, as shown in Fig. 6 . However, the calculated maximal cholesterol output of this group decreased from 16 to 3 nmol/g per min (panel A, Fig.  6 ). This last figure was similar to the maximal cholesterol output calculated for the control rats (panel A, Fig. 3) .
To study the effect of dietary cholesterol on biliary cholesterol secretion induced by diosgenin feeding, we injected intravenously a series of diosgenin-fed rats with different doses of chylomicron cholesterol. After 12 h of the injection we studied biliary cholesterol output (Fig. 7) . We chose this preparation because diosgenin feeding interferes with dietary cholesterol absorption (21, 37 Hepatic cholesterol concentration remained in the normal range. When the diosgenin-fed animal received EE then, as expected, hepatic cholesterol esters increased by 500% and cholesterol synthesis decreased, which indicated that in these animals the feed-back regulatory mechanism of hepatic cholesterogenesis was functioning. The high rates of hepatic cholesterogenesis induced by diosgenin are probably the result of its capacity to block dietary cholesterol absorption (21) and to increase the loss of cellular cholesterol through the canalicular membrane.
To investigate whether the high rate of biliary cholesterol in diosgenin-fed rats injected with EE. The animals were fed 1% diosgenin for 6 d. In addition, a group received two daily doses of 2 mg/k body weight of EE before the experiments. The diosgenin group injected with corn oil was formed with the four animals of group B from Table II, which after the initial bile sample were intravenously infused with 45 mM taurocholate at a rate of 0.075 ml/min for a period of 20 mm, and two rats were subjected to acute depletion of the bile acid pool (12 bile samples). The diosgenin group injected with EE was formed with the five animals of group C from Table II , which were also infused with taurocholate, and two rats subjected to acute depletion of the bile acid pool. The terms a and b of the EE-injected rats ((3)) were significantly decreased (P < 0.001) compared with the diosgenin-fed rats animals injected with corn oil. output found in the diosgemn-fed animal was the result of the increased hepatic cholesterogenesis induced by the drug, we quantitated the contribution of newly synthesized cholesterol to biliary cholesterol by using the tritiated water method of Turley and Dietschy (9) . Although the diosgenin-fed rat secreted more newly synthesized cholesterol than the control animal by a factor of 5, it was apparent, as shown in panel B of control and 19% in the diosgenin-fed rat; however, the difference was not statistically significant. These percentages of contribution of newly synthesized hepatic cholesterol to biliary cholesterol are in the range of those previously communicated (9) .
These experiments demonstrated that the absolute increment of biliary cholesterol output induced by diosgenin was not the result of its capacity to increase hepatic cholesterogenesis. It was apparent that the drug specifically increased the size of the precursor pool of biliary cholesterol through a different mechanism.
The final series of experiments was performed to study the role of hepatic cholesterol esterification as a major determinant of the size of the hepatic free cholesterol precursor pool, from which biliary cholesterol originates. The rate of oleate incorporation into cholesterol esters was significantly decreased in hbepatocytes isolated from diosgenin-fed rats, whereas EE stimulated esterification by 300% (Table III) . Whether the inhibition of hepatic cholesterol esterification induced by diosgenin was the result of a direct inhibitory effect of the drug on the microsomal enzyme ACAT or a secondary deficiency of metabolically active free cholesterol as substrate for the enzyme cannot be determined with our data. The concentration of free cholesterol in the environment of the enzyme is one of the major determinants of its activity (38-42). Although the microsomal free cholesterol concentration was normal in diosgenin-fed rats (Table IV) , this may not necessarily indicate the true concentration of free cholesterol that has access to the active site of the ACAT (38). The stimulation of this enzyme by EE is probably related to the enhanced uptake of serum low density lipoproteins (LDL) through the increment of LDL receptors at the sinusoidal membranes (43, 44) . In this manner, the hormone stimulates cholesterol esterification through the overloading ofthe microsomal membranes with higher amounts of free cholesterol (Table IV) . EE appears to be ineffective as a direct stimulator of the ACAT reaction (20, 45) .
To examine the relationship between hepatic cholesterol esterification and biliary cholesterol output we correlated both parameters in a series of 21 diosgenin-fed rats. Six of them Fig. 9 ) and the concentration of hepatic cholesterol esters (panel B, Fig. 9 ). The correlation coefficients between ACAT activity and hepatic cholesterol ester concentration was 0.91 (P < 0.001). There was no correlation between biliary cholesterol output and hepatic or microsomal free cholesterol concentrations. These experiments demonstrated that the size of the biliary cholesterol precursor pool could be rapidly modulated by the activity of the ACAT reaction. Although both experimental maneuvers, EE and chylomicron cholesterol injections, overloaded the hepatocyte with extrahepatic cholesterol, it is apparent that this cholesterol in excess is not immediately accessible to the biliary precursor pool. Nevertheless, this precursor pool appears to be closely connected with the subcellular organelles where the esterification of hepatic cholesterol takes place.
Discussion
The present results demonstrate that diosgenin when fed to rats induces biliary cholesterol supersaturation by increasing biliary cholesterol secretion. This effect was rapidly reversed by either EE or chylomicron cholesterol. The contribution of newly synthesized hepatic cholesterol to biliary cholesterol output increased 500% in the diosgenin-fed rat. However, its relative contribution to the absolute rate of biliary cholesterol output remained in the range found in control animals. When we increased the size of the hepatic cholesterol ester pool by the administration of EE or chylomicron cholesterol to diosgenin-fed rats, we found a negative reciprocal correlation between both parameters of hepatic cholesterol metabolism and the rate of biliary cholesterol output.
A remarkable observation of this study is the selective effect of diosgenin on biliary cholesterol output. The precise mechanism, however, has not been clearly elucidated by our experiments. A direct detergent effect of diosgenin or some of its hydroxylated metabolites (22) on the structural integrity of the biliary apparatus seems very unlikely, because bile flow, biliary phospholipid and protein outputs, and the biliary secretory function under high taurocholate infusion remained unchanged in the diosgenin-fed animal. A phospholipid-or bile salt-like effect of diosgenin metabolites in enhancing solubilization of biliary cholesterol is inconsistent with our observations. The appearance of cholesterol nucleation in bile specimens from diosgenin-fed rats after freezing and thawing was a strong evidence against this possibility. The third more likely interpretation relates to some effect of diosgenin on the intrahepatocytic regulatory mechanisms of biliary cholesterol output. Hepatic cholesterol esterification decreased by 30% in the isolated hepatocyte from diosgenin-fed animals. If the drug directly inhibits cholesterol esterification, then the availability of free cholesterol may have increased in the hepatocytic biliary precursor pool, as we previously postulated for the progesterone-induced biliary cholesterol output (19, 20) . However, the lower hepatic esterification rate of diosgenin-fed rats may also be related to a decreased availability of microsomal free cholesterol, which acts as substrate for the ACAT reaction. It is known that this pool is small (38) and that the major proportion of free cholesterol present in the microsomal fraction represents cholesterol from plasma and Golgi membrane (46, 47) , and, therefore, is not available as a substrate pool for Diosgenin-fed and EE-injected rats were prepared as described in Fig. 6 . Body weights of these animals were between 135 and 150 g. They received an intravenous dose of 70 mCi of tritiated water in 0.5 ml of 0.9% NaCl at 08:30 under light ether anesthesia. 6 h later the animals were anesthetized with pentobarbital and bile was collected for a period of 60 min. Each bar represents the mean± I SD of four rats in each group.
cholesterol esterification, a metabolic process located in the endoplasmic reticulum membranes (48) . If diosgenin decreases the availability of free cholesterol in the environment of the ACAT as a secondary phenomenon determined by the high biliary cholesterol output, then a different, unknown mechanism responsible for the regulation of the size of the biliary cholesterol precursor pool should be invoked as an explanation for the diosgenin-induced biliary cholesterol output. The reversal of diosgenin-induced biliary cholesterol output by two known stimulators of the ACAT reaction, EE (20, 49) and dietary cholesterol (20, 38) , is a strong evidence favoring the thesis that postulates a functional relationship between biliary cholesterol output and hepatic cholesterol esterification. The activity of the ACAT in the endoplasmic reticulum of the hepatocyte would be a major determinant of the size of the Although there are remarkable differences between species in the rates of biliary cholesterol output, particularly between rat and man, their major regulatory mechanism is related to the canalicular transport of bile salts in all species so far studied (11) (12) (13) (14) (15) (16) 
